NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmalundensis AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
31
|
46
|
41 |
| Earnings before taxes |
-316
|
-397
|
-295 |
| EBITDA |
-190
|
-258
|
-235 |
| Total assets |
877
|
988
|
787 |
| Current assets |
137
|
252
|
56 |
| Current liabilities |
394
|
239
|
213 |
| Equity capital |
338
|
285
|
158 |
| - share capital |
220
|
190
|
134 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.5%
|
28.8%
|
20.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-32.5%
|
-35.5%
|
-32.3% |
| Current ratio |
34.8%
|
105.4%
|
26.3% |
| Return on equity (ROE) |
-93.5%
|
-139.3%
|
-186.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.